Eric Bjerkholt - 11 Sep 2024 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Judit Ryvkin, Attorney-in-Fact
Issuer symbol: MIRM
Transactions as of: 11 Sep 2024
Net transactions value: $0
Form type: 4
Filing time: 12 Sep 2024, 16:18:50 UTC
Previous filing: 28 Aug 2024
Next filing: 14 Nov 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MIRM	Common Stock	Options Exercise		+18,334	+127%		32,804	11 Sep 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MIRM	Restricted Stock Units	Options Exercise	$0	-18,334	-33%	$0.000000	36,666	11 Sep 2024	Common Stock	18,334		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
F2	The restricted stock units vest in a series of three successive equal annual installments beginning on the one-year anniversary of September 11, 2023.